Cigna Expands Coverage for Home Phototherapy -- No Restrictions
CI(NYSE:CI) More than 66.7 million Americans now covered for safe, effective at-home treatment for psoriasis, eczema, and vitiligo BRYAN, Ohio, Aug. 29, 2025 /PRNewswire/ -- Phothera announced today that Cigna has updated its coverage policy to remove prior restrictions on home phototherapy,...
Cantor Fitzgerald Initiates Coverage on ACG Metals with 'Buy (Speculative)' Rating
LONDON, Aug. 22, 2025 /PRNewswire/ -- ACG Metals Ltd. ("ACG" or the "Company") is pleased to announce that Cantor Fitzgerald Canada Corporation ("Cantor"), a leading global investment bank, has initiated equity research coverage on the Company. Cantor Initiates Equity Research Coverage on...
Clear Street Initiates Coverage of Amber International (AMBR) with "Buy" Rating and a Target Price of $11
AMBRNEW YORK, Aug. 21, 2025 /PRNewswire/ -- Clear Street has initiated coverage of Amber International (NASDAQ: AMBR) with a "Buy" rating and a target price of $11.00, representing a significant upside from AMBR's recent closing price of $5.34. According to Clear Street's report[1], the stock...
Elucid’s PlaqueIQ™ Image Analysis Software Now Covered by United Healthcare
BOSTON--(BUSINESS WIRE)-- #histologymatters--Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, announced that United Healthcare has updated its cardiac imaging guidelines to fully align with recent recommendations from radiology benefit manager EviCore. United Healthcare’s new guidelines now include coronary computed tomography angiography (CTA) plaque quantification (see page 520), specifically enco
STRATA Skin Sciences Moves to Accelerate Medicare and Private Payer Coverage from Expanded CPT Code Expansion, Tripling Addressable Market to 30M+ Patients
STRATPeer-reviewed publications continue to validate Excimer Laser efficacy in vitiligo and treatment
CareFirst BCBS Recognizes Nalu Neurostimulation System as Medically Necessary for Chronic Peripheral Pain, Expanding Access to 3.5 Million Covered Lives
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc., a leader in miniaturized neuromodulation therapies for chronic neuropathic pain, is pleased to announce that CareFirst BCBS has issued an updated medical coverage policy designating the Nalu Neurostimulation System as medically necessary in treatment of chronic pain of peripheral origin. This change, effective August 4th, 2025, follows a review by CareFirst of Nalu clinical data, inclusive of the recently published COMFORT 2 confirmatory ra